Target intelligence / Profile preview

SSX family member 14, pseudogene (SSX14P)

Target: SSX14P
Molecular classification: Other (pseudogene)

Overview

SSX family member 14, pseudogene (SSX14P; psiSSX4) is a member of the SSX gene family, which includes both protein-coding genes and pseudogenes. Unlike its protein-coding relatives (such as SSX4), SSX14P is a pseudogene, meaning it has lost its ability to encode a functional protein, generally due to mutations or truncations within its sequence. As a pseudogene, SSX14P has no confirmed role as a therapeutic target, biological function, or disease association in humans[4]. In the context of the SSX family, active members function as cancer-testis antigens and are investigated as potential immunotherapy targets in cancers such as synovial sarcoma and melanoma[1][2][3][5], but SSX14P itself is not implicated in these roles.

Other names: psiSSX4SSX pseudogene 14

Beyond the preview

Go deeper on SSX family member 14, pseudogene (SSX14P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SSX family member 14, pseudogene (SSX14P).

Explore the full profile